Clinical Trial Update: "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia [Phase 3]

View source ↗

Summary

Phase 3 SALT-2 trial evaluating ascending doses of tolvaptan for hyponatremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Electrolyte Imbalance
• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion
• Water Intoxication

Drugs mentioned

• Samsca (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Hyponatremia, Water Intoxication | Phase 3 | Status: COMPLETED